High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase

Journal of Molecular Biology

Volumn 287, Issue 5, 1999, Pages 983-999

  Schwartz, Heather L ^a   Chandonia, John Marc ^b   Kash, Shera F ^a   Kanaani, Jamil ^a   Tunnell, Evelyn ^a   Domingo, Antoinette ^a   Cohen, Fred E ^b   Banga, J Paul ^c   Madec, Anne Marie ^d   Richter, Wiltrud ^e   Baekkeskov, Steinunn ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITÉ LYON 1   (France)

^e UNIVERSITY OF ULM   (Germany)

Author keywords

Autoantigen; B cell epitopes; Three dimensional structure; Two dimensional structure; Type 1 diabetes

Indexed keywords

AMINO ACID; AUTOANTIGEN; EPITOPE; GLUTAMATE DECARBOXYLASE; HUMAN MONOCLONAL ANTIBODY;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; ENZYME STRUCTURE; EPITOPE MAPPING; EXON; GABAERGIC SYSTEM; HUMAN; HYDROPHILICITY; NERVE CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033574642     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.2655     Document Type: Article

References (57)

1. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
2. Altschul S. F., Madden T. L., Schaffer A. A., Zhang Z., Zhang Z., Miller W., Lipman D. J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl. Acids Res. 25:1997;3389-3402.
3. Baekkeskov S., Landin M., Kristensen J. K., Srikanta S., Bruining G. J., Mandrup T., Poulson T., de Beaufort C., Soeldner J. S., Eisenbarth G., Lindgren F., Sundquist G., Lernmark A. Antibodies to a Mr 64,000 human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J. Clin. Invest. 79:1987;926-934.
4. Baekkeskov S., Aanstoot H. J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., De Camilli P. The 64kD autoantigen in insulin-dependent diabetes is the GABA synthesizing enzyme glutamic acid decarboxylase. Nature. 347:1990;151-156.
5. Bernstein F. C., Koetzle T. F., Williams G. J., Meyer E. F., Brice M. D., Rodgers J. R., Kennard O., Shimanouchi T., Tasumi M. The Protein Data Bank: a computer based archival file for macromolecular structures. J. Mol. Biol. 112:1977;535-542.
6. Bower M. J., Cohen F. E., Dunbrack J., R. L. Prediction of protein sidechain conformations from a backbone-dependent rotamer library: a new homology modeling tool for proteins: application to side-chain prediction. J. Mol. Biol. 267:1997;1268-1282.
7. Bu D. F., Tobin A. J. The exon-intron organization of the genes (GAD1 and GAD2) encoding two human glutamate decarboxylases (GAD67 and GAD65) suggests that they derive from a common ancestral GAD. Genomics. 21:1994;222-228.
8. Bu D. F., Erlander M. G., Hitz B. C., Tillakaratne N. J. K., Kaufman D. L., Wagner-McPherson C. B., Evans G. A., Tobin A. J. Two human glutamate decarboxylases, 65-kDa Gad and 67-kDa GAD, are each encoded by a single gene. Proc. Natl Acad. Sci. USA. 89:1992;2115-2119.
9. Chandonia J. M., Karplus M. New methods for accurate prediction of protein secondary structure. Proteins: Struct. Funct. Genet. 35:1999;293-306.
10. Chang Y.-C., Gottlieb D. I. Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase. J. Neurosci. 8:1988;2123-2130.
11. Christgau S., Schierbeck H., Aanstoot H.-J., Aagaard L., Begley K., Kofod H., Hejnaes K., Baekkeskov S. Pancreatic β-cells express two autoantigenic forms of glutamic acid decarboxylase, a 65 kDa hydrophilic form and a 64 kDa amphiphilic form which can be both membrane-bound and soluble. J. Biol. Chem. 266:1991;21257-21264.
12. Christgau S., Aanstoot H.-J., Schierbeck H., Begley K., Tullin S., Hejnaes H., Baekkeskov S. Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic β-cells by palmitoylation in the N-terminal domain. J. Cell Biol. 118:1992;309-320.
13. Christie M. R., Daneman D., Champagne P., Delovitch T. L. Persistence of serum antibodies to 64,000-Mr islet cell protein after onset of type I diabetes. Diabetes. 39:1990;653-656.
14. Cunningham B. C., Jhurani P., Ng P., Wells J. A. Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis. Science. 243:1989;1330-1336.
15. Defay T. R., Cohen F. E. Multiple sequence information for threading algorithms. J. Mol. Biol. 262:1996;314-323.
16. Dunbrack R. L. J., Gerloff D. L., Bower M., Chen X., Lichtarge O., Cohen F. E. Meeting Review: the Second meeting on the Critical Assessment of Techniques for Protein Structure Prediction (CASP2), Asilomar, California, December 13-16, 1996. Fold. Design. 2:1997;R27-42.
17. Endl J., Otto H., G. J., Dreisbusch B., Donie F., Stahl P., Elbracht R., Schmitz G., Mein E., Hummel M., Ziegler A.-G., Wank R., Schendel D. J. Identification of naturally processed T-cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J. Clin. Invest. 10:1997;1-11.
18. Erlander M. G., Tillakaratne N. J. K., Feldblum S., Patel N., Tobin A. J. Two genes encode distinct glutamate decarboxylases. Neuron. 7:1991;91-100.
19. Falicov A., Cohen F. E. A surface of minimum area metric for the structural comparison of proteins. J. Mol. Biol. 258:1996;871-892.
20. Hagopian W. A., Michelsen B., Karlsen A. E., Larsen F., Moody A., Grubin C. E., Rowe R., Petersen J., McEvoy R., Lernmark A. Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase. Diabetes. 42:1993;631-636.
21. Hensch T. K., Fagiolini M., Mataga N., Stryker M. P., Baekkeskov S., Kash S. Rapid GABA-release is involved in development of plasticity in the visual cortex. Science. 282:1998;1504-1508.
22. Kash S. F., Johnson R. S., Tecott L. H., Noebels J. L., Mayfield R. D., Hanahan D., Baekkeskov S. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc. Natl Acad. Sci. USA. 94:1997;14060-14065.
23. Kash S. F., Tecott L. H., Hodge C., Baekkeskov S. Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc. Natl Acad. Sci. USA. 96:1999;1698-1703.
24. Kaufman D. L., Houser C. R., Tobin A. J. Two forms of the γ-Aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J. Neurochem. 56:1991;720-723.
25. Kaufman D. L., Clare-Salzler M., Tian J., Forsthuber T., Ting G. S. P., Robinson P., Atkinson M. A., Sercarz E. E., Tobin A. J., Lehmann P. V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:1993;69-72.
26. Kim J., Namchuk M., Bugawan D., Fu Q., Jaffe M., Shi Y., Aanstoot H.-J., Turck C., Erlich H., Lennon V., Baekkeskov S. Higher autoantibody levels and recognition of a linear N-terminal epitope in the autoantigen GAD65 distinguish stiff-man syndrome from insulin dependent diabetes mellitus. J. Exp. Med. 180:1994;595-606.
27. Kunkel T. A., Roberts J. D., Zakour R. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:1987;367-382.
28. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
29. Lorish T. R., Thorsteinssen G., Howard F. M. Stiff-man syndrome updated. Mayo Clin. Proc. 64:1989;629-636.
30. Madec A.-M., Rousset F., Ho S., Robert F., Thivolet C., Orgiazzi J., Lebecque S. Four IgG anti-islet human monoclonal antibodies isolated from a type 1 diabetes patient recognize distinct epitopes of glutamic acid decarboxylase 65 and are somatically mutated. J. Immunol. 156:1996;3541-3549.
31. Martin J. M., Lacey P. E. The prediabetic period in partially pancreatectomized rats. Diabetes. 12:1963;238-242.
32. Miyazawa S., Jernigan R. L. Estimation of effective interresidue contact energies from protein crystal structures: quasi-chemical approximation. Macromolecules. 18:1985;534-552.
33. Momany C., Ernst S., Ghosh R., Hackert M. L. Crystallographic structure of a PLP-dependent ornithine decarboxylase from Lactobacillus 30a to 3.0 A resolution. J. Mol. Biol. 252:1995a;643-655.
34. Momany C., Ghosh R., Hackert M. L. Structural motifs for pyrodoxal-5′-phosphate binding in decarboxylases: an analysis based on the crystal structure of the Lactobacillus 30a ornithine decarboxylase. Protein Sci. 4:1995b;849-854.
35. Patel S. D., Cope A. P., Congia M., Chen T. T., Kim E., Fugger L., Wherret D., Sonderstrup-McDevitt G. Identification of immunodominant T-cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR (alpha1*0101, beta1*0401) transgenic mice. Proc. Natl Acad. Sci. USA. 15:1997;8082-8087.
36. Perrin S., Gilliland G. Site-specific mutagenesis using asymmetric polymerase chain reaction and a single mutant primer. Nucl. Acids Res. 18:1990;7433-7438.
37. Petersen J. S., Hejnaes K. R., Moody A., Karlsen A. E., Marshall M. O., Hoier-Madsen M., Boel E., Michelsen B. K., Dyrberg T. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes. 43:1994;459-467.
38. Reetz A., Solimena M., Matteoli M., Folli F., Takei K., DeCamilli P. GABA and pancreatic β-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic like microvesicles suggests their role in GABA storage and secretion. EMBO J. 10:1991;1275-1284.
39. Richter W., Shi Y., Baekkeskov S. Autoreactive epitopes in glutamic acid decarboxylase defined by diabetes-associated human monoclonal antibodies. Proc. Natl Acad. Sci. USA. 90:1993;2832-2836.
40. Ridsdale R. A., Beniac D. R., Tompkins T. A., Moscarello M. A., Harauz G. Three-dimensional structure of myelin basic protein. J. Biol. Chem. 272:1997;4269-4275.
41. Sali A., Blundell T. L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234:1993;779-815.
42. Sandmeier E., Hale T. I., Christen P. Multiple evolutionary origin of pyrodoxal-5′-phosphate-dependent amino acid decarboxylases. Eur. J. Biochem. 221:1994;997-1002.
43. Schagger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:1987;368-379.
44. Sheikh S. N., Martin D. L. Elevation of brain GABA levels with vigabatrin (γ-vinyl GABA) differentially affects GAD65 and GAD67 expression in various regions of rat brain. J. Neurosci. Res. 52:1996;736-741.
45. Shi Y., Veit B., Baekkeskov S. Amino acid residues 24-31 but not palmitoylation of cysteines 30 and 45 are required for membrane anchoring of glutamic acid decarboxylase, GAD65. J. Cell Biol. 124:1994;927-934.
46. Simitsek P. D., Campbell D. G., Lanzavecchia A., Fairweather N., Watts C. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T-cell determinants. J. Exp. Med. 181:1995;1957-1963.
47. Solimena M., Folli F., Aparisi R., Pozza G., De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic β-cells in stiff-man syndrome. N. Engl. J. Med. 322:1990;1555-1560.
48. Syren K., Lindsay L., Stoehrer B., Jury K., Luhder F., Baekkeskov S., Richter W. Immune reactivity of diabetes associated human monoclonal antibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase. J. Immunol. 157:1996;5208-5214.
49. Taylor W. R. A template based method of pattern matching in protein sequences. Prog. Biophys. Mol. Biol. 54:1989;159-252.
50. Thompson J. D., Higgins D. G., Gibson T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucl. Acids Res. 22:1994;4673-4680.
51. Tian J., Lehmann P. V., Kaufman D. L. T-cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J. Exp. Med. 180:1994;1979-1984.
52. Tisch R., Yang X.-D., Singer S. M., Liblau R. S., Fugger L., McDevitt H. O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:1993;72-75.
53. Toney M. D., Hohenester E., Keller J. W., Jansonius J. N. Structural and mechanistic analysis of two refined crystal structures of the pyridoxal phosphate-dependent enzyme dialkylglycine decarboxylase. J. Mol. Biol. 245:1995;151-179.
54. Tremble J., Morgenthaler N. G., Vlug A., Powers A. C., Christie M. R., Scherbaum W. A., Banga J. P. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' Disease: a comparison with those present in type 1 diabetes. J. Clin. Endocrinol. Metab. 82:1997;2664-2670.
55. Wicker L. S., Chen S. L., Nepom G. T., Elliott J. F., Freed D. C., Bansal A., Zheng S., Herman A., Lernmark A., Zaller D. M., Peterson L. B., Rothbard J. B., Cummings R., Whiteley P. J. Naturally processed T-cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J. Clin. Invest. 98:1996;2597-2603.
56. Wucherpfennig K. W., Catz I., Hausmann S., Strominger J. L., Steinman L., Warren K. G. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T-cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes. J. Clin. Invest. 100:1997;1114-1122.
57. Zekzer D., Wong F. S., Ayalon O., Millet I., Altieri M., Shintani S., Solimena M., Sherwin R. S. GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice. J. Clin. Invest. 101:1998;68-73.